These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22918)

  • 1. [Characteristics of malignant lymphoproliferative syndromes in the aged].
    Popa G; Popa M; Iordăcheanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):359-62. PubMed ID: 22918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 3. Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion.
    Anderson LJ; Jarrett WF; Jarrett O; Laird HM
    J Natl Cancer Inst; 1971 Oct; 47(4):807-17. PubMed ID: 5286051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic characterization and clinical evaluation of 15 patients with lymphoblastic lymphoma.
    Kita K; Nasu K; Kamesaki H; Doi S; Tezuka H; Sawada H; Fukuhara S; Nishikori M; Uchino H; Fukumoto M
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):89-98. PubMed ID: 3873777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heterogenicity of human blood lymphocytes. II. Studies in chronic lymphadenosis].
    Michlmayr G; Asamer H; Huber C; Huber H; Braunsteiner H
    Verh Dtsch Ges Inn Med; 1971; 77():392-5. PubMed ID: 5172770
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune deficiency in malignant lymphomas.
    Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
    Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxoplasmosis and malignant lymphoproliferative disease. A case report].
    Tangen JM
    Tidsskr Nor Laegeforen; 1983 Jun; 103(16):1329-30. PubMed ID: 6688686
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new physio-morphological approach to malignant non hodgkinian lymphomas].
    Cabanne PF
    Bull Cancer; 1974; 61(1):1-9. PubMed ID: 4617605
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of cytoplasmic immunologlobulin in well-differentiated lymphoproliferative diseases by the immunoperoxidase method.
    Pangalis GA; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1334-9. PubMed ID: 6986977
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune deficiency states associated with malignant disease in man.
    Harris J; Bagai RC
    Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
    [No Abstract]   [Full Text] [Related]  

  • 14. HL-A and lymphoid tumors.
    Dick FR; Fortuny I; Theologides A; Greally J; Wood N; Yunis EJ
    Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2.
    Adams RA; Flowers A; Davis BJ
    Cancer Res; 1968 Jun; 28(6):1121-5. PubMed ID: 4872716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular immunologic defects in diseases of the lymphoreticular system].
    Warnatz H
    Med Welt; 1972 Oct; 23(44):1573-5. PubMed ID: 5085863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of determination of the activity of terminal deoxyribonucleotidyl transferase in lymphoproliferative syndromes].
    Brodzki LM
    Acta Haematol Pol; 1980; 11(1):49-54. PubMed ID: 6989144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of immunoregulation using the TFX Polfa preparation in non-Hodgkin's lymphoma].
    Górski J; Kicińska M; Gawrecka G
    Przegl Lek; 1988; 45(7):555-8. PubMed ID: 3070639
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of neuropathological changes in the central nervous system of 51 patients who died from proliferative hematological diseases.
    Iwanowski L; Czechowska Z; Sielczak M
    Neuropatol Pol; 1985; 23(4):531-43. PubMed ID: 3868742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.